| 000 | 01764 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250511214853.0 | ||
| 264 | 0 | _c19920818 | |
| 008 | 199208s 0 0 eng d | ||
| 022 | _a0895-0172 | ||
| 024 | 7 |
_a10.1176/jnp.2.1.20 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrandt, J | |
| 245 | 0 | 0 |
_aD2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates. _h[electronic resource] |
| 260 |
_bThe Journal of neuropsychiatry and clinical neurosciences _c1990 |
||
| 300 |
_a20-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
| 650 | 0 | 4 | _aBrain Mapping |
| 650 | 0 | 4 |
_aCaudate Nucleus _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCerebellum _xdiagnostic imaging |
| 650 | 0 | 4 |
_aDopamine Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHuntington Disease _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeuropsychological Tests |
| 650 | 0 | 4 |
_aPutamen _xdiagnostic imaging |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xphysiology |
| 650 | 0 | 4 | _aReceptors, Dopamine D2 |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSpiperone _xanalogs & derivatives |
| 650 | 0 | 4 | _aTomography, Emission-Computed |
| 700 | 1 | _aFolstein, S E | |
| 700 | 1 | _aWong, D F | |
| 700 | 1 | _aLinks, J | |
| 700 | 1 | _aDannals, R F | |
| 700 | 1 | _aMcDonnell-Sill, A | |
| 700 | 1 | _aStarkstein, S | |
| 700 | 1 | _aAnders, P | |
| 700 | 1 | _aStrauss, M E | |
| 700 | 1 | _aTune, L E | |
| 773 | 0 |
_tThe Journal of neuropsychiatry and clinical neurosciences _gvol. 2 _gno. 1 _gp. 20-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1176/jnp.2.1.20 _zAvailable from publisher's website |
| 999 |
_c1989954 _d1989954 |
||